NCT01453608View on ClinicalTrials.gov

A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

January 31, 2015

Conditions
Iron DeficiencyChronic Heart Failure
Interventions
DRUG

Ferinject (ferric carboxymaltose)

Subjects will receive Ferinject (ferric carboxymaltose) intravenously on Day 0

DRUG

Placebo (saline)

Subjects will receive Placebo (saline) intravenously on Day 0

Trial Locations (2)

390039

State Educational Institution of Higer Professional Education, Ryazan

50-891

Clinical Military Hospital, Wroclaw

Sponsors

Lead Sponsor

Vifor Pharma

Collaborators (1)

ICON Clinical Research
All Listed Sponsors
collaborator

ICON Clinical Research

INDUSTRY

lead

Vifor Pharma

INDUSTRY